Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma-Reference-Cited by-同舟云学术

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma

Published:2018-02-14 Issue:12 Volume:142 Page:2610-2620
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Lindner Lars H.¹^ORCID,Litière Saskia²,Sleijfer Stefan³^ORCID,Benson Charlotte⁴,Italiano Antoine⁵^ORCID,Kasper Bernd⁶,Messiou Christina⁴,Gelderblom Hans⁷,Wardelmann Eva⁸,Le Cesne Axel⁹,Blay Jean-Yves¹⁰,Marreaud Sandrine²,Hindi Nadia¹¹,Desar Ingrid M.E.¹²,Gronchi Alessandro¹³,van der Graaf Winette T.A.⁴¹⁴

Affiliation:

1. Klinikum der Universität München, Interdisciplinary Tumor Center (CCC LMU), Sarcoma Unit (SarKUM), Marchioninistr. 15; München D-81377 Germany

2. European Organisation for Research and Treatment of Cancer (EORTC) Data Centre, Avenue Mounier 83/11; Brussels B-1200 Belgium

3. Erasmus MC Cancer Institute, Groene Hilledijk 301; Rotterdam EA 3075 The Netherlands

4. The Sarcoma Unit; Royal Marsden NHS Foundation Trust, Fulham Road; London SW3 6JJ United Kingdom

5. Department of Medical Oncology, 229 cours de l'Argonne; Institut Bergonie; Bordeaux Cedex 33076 France

6. University of Heidelberg, Mannheim University Medical Center, Interdisciplinary Tumor Center, Sarcoma Unit, Theodor-Kutzer-Ufer 1-3; Mannheim D-68167 Germany

7. Department of Clinical Oncology; Leiden University Medical Centre, Albinusdreef 2; Leiden ZA 2333 The Netherlands

8. Gerhard-Domagk-Institut für Pathologie, Universitätsklinikum Münster; Münster 48149 Germany

9. Institut Gustave Roussy; Villejuif France

10. Department of Medicine, NetSARC and LYRIC; Centre Leon Berard; Lyon France

11. Department of Medical Oncology; University Hospital Virgen del Rocio and Biomedicine Research Institute (IBIS); Sevilla Spain

12. Radboud University Medical Center Nijmegen; the Netherlands

13. Department of Surgery-Sarcoma Service; Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1; Milan 20133 Italy

14. Division of Clinical Studies; Institute of Cancer Research; Sutton United Kingdom

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31286/fullpdf

Reference31 articles.

1. Incidence and survival in sarcoma in the United States: a focus on musculoskeletal lesions;Ng;Anticancer Res,2013

2. The burden of rare cancers in Europe;Gatta;Adv Exp Med Biol,2010

3. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities;Pisters;JCO,1996

4. Metastasis in soft tissue sarcomas: prognostic criteria and treatment perspectives;Komdeur;Cancer Metastasis Rev,2002

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma – A retrospective multicenter study of the Bavarian university hospitals;European Journal of Surgical Oncology;2024-12

2. A multimodal neural network with gradient blending improves predictions of survival and metastasis in sarcoma;npj Precision Oncology;2024-09-05

3. Establishing biomarkers for soft tissue sarcomas;Expert Review of Anticancer Therapy;2024-04-30

4. Improved local control following dose-escalated stereotactic ablative radiation therapy (SABR) for metastatic sarcomas: An international multi-institutional experience;Radiotherapy and Oncology;2024-01

5. Unraveling the Role of Local Ablative Therapies for Patients with Metastatic Soft Tissue Sarcoma – a Retrospective Multicenter Study of the Bavarian University Hospitals;2024